Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
Boehringer Ingelheim
Boehringer Ingelheim
Rutgers, The State University of New Jersey
Cyteir Therapeutics, Inc.
BeiGene
Jazz Pharmaceuticals
Eli Lilly and Company
OHSU Knight Cancer Institute
OHSU Knight Cancer Institute
Genzada Pharmaceuticals USA, Inc.
Silverback Therapeutics
University of Kansas Medical Center
Montefiore Medical Center
University Hospital, Limoges
Newcastle-upon-Tyne Hospitals NHS Trust
Qilu Pharmaceutical Co., Ltd.
Jules Bordet Institute
Hoffmann-La Roche
PharmaMar
Hoffmann-La Roche
Yale University
Hoffmann-La Roche
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
NYU Langone Health